CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)
Balances, beginning of period (Shares) at Jul. 03, 2021			10,762,000
Balances, beginning of period at Jul. 03, 2021	$ 123,705		$ 47,181	$ 74,452		$ 2,072
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	3,377			3,377
Unrealized gain (loss) on hedging instruments, net of tax	(2,497)					(2,497)
Share-based compensation	$ 293		$ 293
Balances, end of period (Shares) at Jul. 02, 2022	10,762,000		10,762,000
Balances, end of period at Jul. 02, 2022	$ 124,878		$ 47,474	77,829		(425)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,157			5,157
Unrealized gain (loss) on hedging instruments, net of tax	328					328
Share-based compensation	$ 254		$ 254
Balances, end of period (Shares) at Jul. 01, 2023	10,762,000		10,762,000
Balances, end of period at Jul. 01, 2023	$ 130,617	$ (3,278)	$ 47,728	82,986	$ (3,278)	(97)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13
Net income (loss)	$ 335
Balances, end of period (Shares) at Sep. 30, 2023	10,762,000
Balances, end of period at Sep. 30, 2023	$ 127,790
Balances, beginning of period (Shares) at Jul. 01, 2023	10,762,000		10,762,000
Balances, beginning of period at Jul. 01, 2023	$ 130,617	$ (3,278)	$ 47,728	82,986	$ (3,278)	(97)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(2,787)			(2,787)
Unrealized gain (loss) on hedging instruments, net of tax	(118)					(118)
Share-based compensation	$ (444)		$ (444)
Balances, end of period (Shares) at Jun. 29, 2024	10,762,000		10,762,000
Balances, end of period at Jun. 29, 2024	$ 123,990		$ 47,284	$ 76,921		$ (215)
Balances, beginning of period (Shares) at Sep. 30, 2023	10,762,000
Balances, beginning of period at Sep. 30, 2023	$ 127,790
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 1,084
Balances, end of period (Shares) at Dec. 30, 2023	10,762,000
Balances, end of period at Dec. 30, 2023	$ 129,157
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ (2,221)
Balances, end of period (Shares) at Mar. 30, 2024	10,762,000
Balances, end of period at Mar. 30, 2024	$ 126,797